Towards optimal design of anti-malarial pharmacokinetic studies
<p>Abstract</p> <p>Background</p> <p>Characterization of anti-malarial drug concentration profiles is necessary to optimize dosing, and thereby optimize cure rates and reduce both toxicity and the emergence of resistance. Population pharmacokinetic studies determine the...
Main Authors: | White Nicholas J, Price Ric N, Jamsen Kris M, Simpson Julie A, Lindegardh Niklas, Tarning Joel, Duffull Stephen B |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-08-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/8/1/189 |
Similar Items
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
by: Lindegardh Niklas, et al.
Published: (2011-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
by: Jamsen Kris M, et al.
Published: (2012-07-01) -
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
by: Zaloumis Sophie, et al.
Published: (2012-08-01) -
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
by: Tarning Joel, et al.
Published: (2010-10-01) -
The role of anti-malarial drugs in eliminating malaria
by: White Nicholas J
Published: (2008-12-01)